speaker photo

David Elsley

President and CEO

Cardiol Therapeutics

David Elsley, president and CEO of Cardiol Therapeutics, has more than 25 years of experience developing, financing, and managing all aspects of corporate development of biotechnology and high-growth organizations. He is also the founder and former president and CEO of Vasogen, Inc.

Cardiol Therapeutics

Speaker Schedule

Wednesday, June 10, 2020 - 4:50 pm to 5:20 pm EDT Innovative Pharmaceutical Cannabidiol (CBD) Therapies for Heart Disease Focus: BIOTECH

David Elsley, president and CEO, provides a corporate presentation on how Cardiol Therapeutics (TSX:CRDL) is focused on producing pharmaceutical cannabidiol (CBD) products and developing innovative therapies for heart diseases, including acute myocarditis and other causes of heart failure. The Company's lead product, CardiolRx™, is formulated to be the most consistent cannabidiol formulation on the market. CardiolRx— is pharmaceutically produced, manufactured under cGMP, and is THC free (<5 ppm). The Company also plans to commercialize CardiolRx— in the billion-dollar market for medicinal cannabinoids in Canada and is pursuing distribution opportunities in Europe and Latin America.


For questions please contact our Client Relations Team at 800-970-4355 or 941-955-0323.

Social Updates

Follow us on social media to stay in the loop as more great speakers are added to the schedule!